Search Results
Jun 01, 2026, 06:22 ET Nagarro recognized by ISG as CX Star Performer and Leader in Digital Engineering Services for Midsize providers
Engineering through its strong leadership in Augmented Design & R&D Services and Integrated Platform and Application Services. Its engineering–first DNA, combined with design–led thinking and AI–native execution, enables enterprises to build, modernize, and scale digital products and platforms with speed
More news about: Nagarro
Jun 01, 2026, 06:01 ET A combined therapeutic strategy aims to improve disease control in advanced hormone‑sensitive prostate cancer
combining it with talazoparib (a PARP inhibitor, a protein involved in DNA repair) from earlier stages of the disease. By administering both drugs together while the disease is still hormone‑sensitive, the goal is to increase the accumulated DNA damage in tumor cells and promote their destruction before mechanisms
More news about: MEDSIR
May 31, 2026, 12:03 ET iHuman Inc. Announces Acquisition of Businesses and Assets Related to All Knowledge and Perfect Lingo
a deep legacy that combines nearly three decades of experience in the parenthood industry, superior original content, advanced high-tech innovation DNA and research & development capabilities with cutting-edge technologies, iHuman empowers parents with tools to make the child-upbringing experience
More news about: iHuman Inc.
May 30, 2026, 20:00 ET Sacituzumab Tirumotecan (sac-TMT) in Combination with Pembrolizumab for First-Line Treatment of PD-L1-Positive NSCLC Published in The Lancet
antibodies, which is then endocytosed by tumor cells and releases the payload KL610023 intracellularly. KL610023, as a topoisomerase I inhibitor, induces DNA damage to tumor cells, which in turn leads to cell-cycle arrest and apoptosis. In addition, it also releases KL610023 in the tumor microenvironment.
More news about: Kelun-Biotech
May 30, 2026, 06:36 ET Chandigarh University Research Scientist Receives Startup Research Grant of Rs 24 Lakhs
project, Dr Vijay Gahlaut said, "Our project is titled Elucidating the Role of DNA Methylation under Elevated CO2 and Temperature During Grain Filling in Wheat (Triticum aestivum L) is primarily aimed at understanding how DNA methylation patterns change under combined elevated CO2 (carbon-dioxide) and
More news about: Chandigarh University
May 29, 2026, 23:32 ET The Results of Phase III OptiTROP-Lung05 Study of Sacituzumab Tirumotecan (sac-TMT) Presented as an ASCO Oral Presentation and Simultaneously Published in The Lancet
antibodies, which is then endocytosed by tumor cells and releases the payload KL610023 intracellularly. KL610023, as a topoisomerase I inhibitor, induces DNA damage to tumor cells, which in turn leads to cell-cycle arrest and apoptosis. In addition, it also releases KL610023 in the tumor microenvironment.
More news about: Kelun-Biotech
May 29, 2026, 15:56 ET bizZone Launches Autrinity, the World's First AI-Embedded Association Management System (AMS) and the Last AMS You Will Ever Need®
out, controlled through an access control layer, making it highly extensible and secure.""Autrinity was born from the foundation of Association DNA – our traditional AMS that includes a broad range of modules," said Julie King, co-founder and CEO of bizZone. "We have followed Privacy by Design (PbD)
More news about: bizZone Inc.
May 29, 2026, 13:49 ET Die zellfreie Proteinsynthese von Sino Biological unterstützt die in Nature Communications veröffentlichte Protein-Design-Studie des Tencent AI for Life Sciences Lab
StundenHohe Siebeffizienz: optimiert für VHH, scFv und MiniproteineFlexible Template-Unterstützung: kompatibel mit Plasmid- und linearen DNA-TemplatesDisulfidbindungsfreundlich: ermöglicht die Expression komplexer disulfidgebundener Proteine ohne zusätzliche EnhancerKostengünstige
More news about: Sino Biological, Inc.
May 29, 2026, 07:38 ET Kao Data Appoints Spencer Lamb as Chief Executive Officer
Chairman at Kao Data, said: "Spencer's appointment formalises what has been an increasingly natural evolution in how we lead this business. He has the DNA of this company and is, quite simply, a 'Kao person' through and through and an outstanding leader in this industry. As CEO, Spencer will drive Kao Data's
More news about: Kao Data
May 28, 2026, 15:18 ET REJUVANT, 획기적인 에이징 셀 시험에서 표준 AKG 및 NAD+를 포함한 모든 테스트 보충제 능가
저자들은 4000명 이상의 초기 시험대상자의 생물학적 연령을 동일하게 결정하기 위해 동일한 DNA 메틸화 시계를 사용하여, 노화 과정에 영향을 미치기 위해 섭취하는 일반적인 보충제, 약물 및 상업용 화합물 84종 간의 연관성을 테스트했다. 그런 다음 해당 결과들을 서로 비교하고 순위를 매겼다. 횡단면 분석에서 통계적 유의성을 달성한 것은 시판 중인 지연 방출형 CaAKG
More news about: Ponce De Leon Health
May 28, 2026, 12:30 ET Illumina and SPT Labtech unveil fireflyGO, enabling faster, simpler targeted oncology research
cancer types including NSCLC, endometrial, AML, B-Cell Lymphoma and MPN.The oncoReveal® Lymphoid Panel is an 84 gene DNA panel spanning high-value B-cell, T-cell, and lymphoblastic markers including full coverage of BTK to help genomically characterize lymphoid malignancies
More news about: Illumina, Inc.
May 28, 2026, 12:00 ET DELFI Diagnostics Receives New York State Department of Health Clinical Laboratory Permit, Completing Authorization to Serve Health Systems Across All 50 States
reliable, offering a new way to help detect cancer. DELFI's proprietary technology leverages advanced AI to analyze patterns of circulating cell-free DNA fragments in the blood, an approach known as fragmentomics, to help detect lung cancer with high sensitivity. FirstLook Lung, the first commercially
More news about: DELFI Diagnostics
May 28, 2026, 11:45 ET Sino Biological's Cell-Free Protein Synthesis Supports Tencent AI for Life Sciences Lab's Protein Design Study Published in Nature Communications
hoursHigh screening efficiency: optimized for VHH, scFv, and miniproteinsFlexible template support: compatible with plasmid and linear DNA templatesDisulfide bond friendly: enables expression of complex disulfide-bonded proteins without additional enhancersCost-effective
More news about: Sino Biological, Inc.
May 28, 2026, 09:15 ET Illumina introduces the first distributed whole-genome sequencing solution for highly sensitive MRD research
including breast, ovarian, and renal.Illumina's first-of-its-kind DRAGEN™ MRD analysis connects each fingerprint to serial circulating tumor DNA (ctDNA), offering customers flexible workflow combinations to meet their specific needs. Leveraging DRAGEN's unparalleled speed and accuracy, the new
More news about: Illumina, Inc.
May 28, 2026, 09:05 ET Nautilus Data Technologies' Facility Cooling Distribution Unit Exceeds Performance Benchmarks for Next-Generation AI GPU Workloads
refinement, in control logic, alarm prioritization, failure handling, and pressure management, that cannot be purchased or shortcut.This operator DNA is embedded directly into the EcoCore FCD's proprietary control logic and systems design, a compound advantage that grows with every additional hour
More news about: Nautilus Data Technologies
May 28, 2026, 09:00 ET Squealing Pig Returns as the Official Wine Sponsor of San Francisco Pride 2026
Vineyard, and Frank Family Vineyards.The company employs a global team of approximately 2,500 people, with its culture best expressed by the 'TWE DNA' – enabling team members to be courageous, bring their whole selves to work, and deliver together. About San Francisco PrideThe
More news about: Treasury Wine Estates
May 28, 2026, 08:05 ET INOVIO to Participate in Upcoming Scientific and Investor Conferences
biotechnology company focused on developing and commercializing DNA medicines to help treat and protect people from HPV-related diseases, cancer, and infectious diseases. INOVIO's technology optimizes the design and delivery of innovative DNA medicines that teach the body to manufacture its own disease-fighting
More news about: INOVIO Pharmaceuticals, Inc.
May 28, 2026, 06:38 ET REJUVANT OUTPERFORMS ALL TESTED SUPPLEMENTS, INCLUDING STANDARD AKG AND NAD+ IN LANDMARK AGING CELL STUDY
the association between 84 commonly used supplements, drugs and commercial compounds taken in an attempt to affect the aging process, using the same DNA methylation clock to uniformly determine the biologic age of over 4,000 initial subjects. Those results were then compared and ranked against one another.
More news about: Ponce De Leon Health
May 28, 2026, 06:38 ET REJUVANT OUTPERFORMS ALL TESTED SUPPLEMENTS, INCLUDING STANDARD AKG AND NAD+ IN LANDMARK AGING CELL STUDY
the association between 84 commonly used supplements, drugs and commercial compounds taken in an attempt to affect the aging process, using the same DNA methylation clock to uniformly determine the biologic age of over 4,000 initial subjects. Those results were then compared and ranked against one another.
More news about: Ponce De Leon Health
May 28, 2026, 06:22 ET Nextview Consulting signs agreement to acquire POLE Consulting to expand in Sweden
doing what we do best, hands-on Salesforce craftsmanship and add the scale within AI our customers increasingly ask for. We share a 100% Salesforce DNA and a belief that the best transformations are designed, not just delivered. This is the right home for our team and the right next chapter for our customers."
More news about: Nextview Consulting
May 28, 2026, 05:15 ET Sino Biological's Cell-Free Protein Synthesis Supports Tencent AI for Life Sciences Lab's Protein Design Study Published in Nature Communications
hoursHigh screening efficiency: optimized for VHH, scFv, and miniproteinsFlexible template support: compatible with plasmid and linear DNA templatesDisulfide bond friendly: enables expression of complex disulfide-bonded proteins without additional enhancersCost-effective
More news about: Sino Biological, Inc.
May 27, 2026, 18:18 ET U.S. FDA Approves DECNUPAZ™ (pivekimab sunirine-pvzy) for Treatment of Adult Patients With Blastic Plasmacytoid Dendritic Cell Neoplasm, an Ultra-Rare and Aggressive Blood Cancer With Limited Treatment Options
in BPDCN, making it an ideal target for therapy. The payload is a member of the indolinobenzodiazepine pseudodimer class that alkylates DNA and causes single-strand DNA breaks without crosslinking, leading to apoptosis and cell death.4In October 2020, the FDA granted pivekimab sunirine-pvzy
More news about: AbbVie
May 27, 2026, 18:00 ET FDA Breakthrough Device Designation Marks Major Milestone for Gene Solutions' SPOT-MAS 10 Multi-Cancer Screening Test
in vitro diagnostic test performed on plasma derived from a single direct-draw venous whole blood specimen. The test analyzes circulating cell-free DNA methylation and fragmentomic signatures using a machine-learning-based algorithm to detect a cancer-associated signal. It is intended for use as an adjunctive
More news about: GENE SOLUTIONS SGP PTE. LTD.
May 27, 2026, 11:13 ET The Dynami Foundation Announces Support of 2026 Conquer Cancer Young Investigator Award Recipient Focused on Invasive Lobular Breast Cancer
care for patients living with ILC."Dr. Rosenzweig's research will examine whether varying radiation strategies, genomic testing, and tumor DNA sequencing can help identify which patients with ILC may be at greater risk. The study will also evaluate distinct metastatic patterns and long-term
More news about: The Dynami Foundation
May 27, 2026, 10:00 ET D'USSÉ® CELEBRATES JAŸ-Z AND THE 30TH ANNIVERSARY OF REASONABLE DOUBT WITH LIMITED-EDITION VSOP BOX SET AND NATIONWIDE ACTIVATIONS
and excellence through a cocktail designed to be shared."Mr. Shawn Carter's codes of ambition, craftsmanship, and excellence are woven into the DNA of D'USSÉ, and JAŸ-Z30 is a powerful reflection of that legacy," says Gigi DaDan, General Manager of D'USSÉ. "For 30 years, he has shaped culture through
More news about: D'USSÉ